Next Generation Sequencing Applications and Sample Prep Workflow Improvements

Watch the Webinar Now


Join us as Josh Stahl, Chief Scientific Officer and General Manager at ArcherDX, discusses the challenges of detecting gene fusions from FFPE samples, the advantages of using Archer™ FusionPlex™ assays and how high-quality nucleic acid purification results in longer reads and higher-complexity libraries. Topics discussed will include:

  • The utility of gene fusion detection in research and the functions of these fusions in tumorigenesis by induced oncogene expression
  • Methods to isolate nucleic acids from formalin-fixed paraffin-embedded (FFPE) specimens
  • The use of total nucleic acid purification in RNA-Seq applications and gene detection

This webinar is co-sponsored by Promega Corporation.


About Josh Stahl

Chief Scientific Officer and General Manager, ArcherDX, Inc.

Josh Stahl

Josh was born and raised in Baltimore, MD and studied biochemistry and molecular biology at West Virginia University. After graduation, he was drawn to Colorado by the snow and mountains. He went to graduate school at the University of Colorado Boulder, where he studied small-molecular perturbation of the TLDR4/MD-2 protein interaction and its effect on morphine analgesia.

After school, he joined Thermo Fisher Scientific, developing gene modulation tools including sequencing-based, high throughput shRNA screening techniques. He joined ArcherDX when the company was in its infancy, specifically to be part of something that would make a lasting impact on healthcare. Josh enjoys skiing, off-roading, mountain biking and playing with his dog Skye.

Subscribe to stay in the loop

How to contact us


2477 55th Street, Suite 202

Boulder, CO 80301


Phone: (877) 771 1093

Phone: (303) 357 9001

All content © 2018 ArcherDX, Inc.

For Research Use Only. Not for use in diagnostic procedures. For Research Use Only. Not for use in diagnostic procedures.